Beyond market averages, investors seeking exceptional growth focus on the art of stock selection. The right picks can significantly contribute to the expansion of your wealth.
As of close of business last night, Psyence Biomedical Ltd’s stock clocked out at $1.82, down -9.45% from its previous closing price of $2.01. In other words, the price has decreased by -$9.45 from its previous closing price. On the day, 2.25 million shares were traded. PBM stock price reached its highest trading level at $1.96 during the session, while it also had its lowest trading level at $1.75.
Ratios:
To gain a deeper understanding of PBM’s stock, we examine its different ratios.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, PBM now has a Market Capitalization of 8057377 and an Enterprise Value of 31295208.
Stock Price History:
The Beta on a monthly basis for PBM is -0.45, which has changed by -0.99768966 over the last 52 weeks, in comparison to a change of 0.23147523 over the same period for the S&P500. Over the past 52 weeks, PBM has reached a high of $945.15, while it has fallen to a 52-week low of $1.51. The 50-Day Moving Average of the stock is -41.43%, while the 200-Day Moving Average is calculated to be -93.87%.
Shares Statistics:
It appears that PBM traded 2.45M shares on average per day over the past three months and 277550 shares per day over the past ten days. A total of 0.72M shares are outstanding, with a floating share count of 0.55M. Insiders hold about 23.47% of the company’s shares, while institutions hold 5.49% stake in the company. Shares short for PBM as of 1735603200 were 76088 with a Short Ratio of 0.03, compared to 1732838400 on 10404. Therefore, it implies a Short% of Shares Outstanding of 76088 and a Short% of Float of 1.7500000000000002.
Earnings Estimates
The consensus estimate for the next quarter is $0, with high estimates of $0 and low estimates of $0.
Analysts are recommending an EPS of between $0 and $0 for the fiscal current year, implying an average EPS of $0.
